Ahrens Investment Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$33.9K Buy
+500
New +$32.1K 0.02% 385
2022
Q3
Sell
-500
Closed -$20K 404
2022
Q2
$20K Hold
500
0.01% 498
2022
Q1
$35K Hold
500
0.01% 465
2021
Q4
$39K Buy
+500
New +$44.1K 0.02% 462

Other funds holding EXAS

Ahrens Investment Partners's EXAS Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Exact Sciences (EXAS) in Q1 2023: 500 shares worth $33.9K. The stake represents 0.02% of the portfolio and ranks #385 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in EXAS as recently as Q2 2022.

Ahrens Investment Partners first reported a position in EXAS in Q4 2021 and has held it in 4 quarters since. The position peaked at $39K in Q4 2021. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Ahrens Investment Partners held 500 shares of Exact Sciences worth $33.9K as of Q1 2023.
  • Exact Sciences was a new Ahrens Investment Partners position in Q1 2023.
  • Exact Sciences made up 0.02% of Ahrens Investment Partners's portfolio in Q1 2023, its #385 holding.
  • Ahrens Investment Partners first reported a position in Exact Sciences in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Exact Sciences position peaked at $39K in Q4 2021.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.